Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Swiss Brassicaceae

ABSTRACT: Whole genome sequencing for genome skimming of Swiss Brassicaceae

PROVIDER: PRJEB28010 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2990210_1.fastq.gz	Fastqsanger.gz
	ERR2990210_2.fastq.gz	Fastqsanger.gz
	ERR2990220_1.fastq.gz	Fastqsanger.gz
	ERR2990220_2.fastq.gz	Fastqsanger.gz
	ERR2990230_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 258

Similar Datasets

Brassicaceae

Project description:Brassicaceae Woodiness raw sequencing data

| PRJNA678873 | ENA

Brassicaceae

Project description:Brassicaceae species transcriptome analysis

| PRJNA242124 | ENA

Brassicaceae

Project description:Further target capture sequencing of the Brassicaceae family Targeted loci

| PRJNA1199212 | ENA

Brassicaceae plastome phylogeny

Project description:Investigating speed and timing of Brassicaceae species diversification based on whole-chloroplast genome sequence data

| PRJEB22719 | ENA

Brassicaceae

Project description:Various representative species from the mustard family (Brassicaceae). Raw sequence reads

| PRJNA806513 | ENA

Encephalitozoon hellem strain:Swiss

Project description:Encephalitozoon hellem strain:Swiss Genome sequencing and assembly

| PRJNA73047 | ENA

Mus musculus strain:NIH/swiss

Project description:Mus musculus strain:NIH/swiss Genome sequencing

| PRJNA252532 | ENA

Mus musculus strain:NIH/swiss

Project description:Mus musculus strain:NIH/swiss Genome sequencing

| PRJNA239280 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Flg22 treatment of Brassicaceae and Arabidopsis thaliana accessions

Project description:We used RNA-seq to profile gene expression changes during flg22 activated pattern-triggered immunity in multiple Brassicaceae including Capsella rubella, Cardamine hirsuta and Eutrema salsugineum as well as in multiple Arabidopsis thaliana accessions. This allows comparative transcriptomics within and across species to investigate the evolution of stress-responsive transcrption changes in these species.

2021-03-11 | GSE115991 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data